138 related articles for article (PubMed ID: 11431375)
1. Mutational analysis of the peroxisome proliferator-activated receptor gamma gene in human malignancies.
Ikezoe T; Miller CW; Kawano S; Heaney A; Williamson EA; Hisatake J; Green E; Hofmann W; Taguchi H; Koeffler HP
Cancer Res; 2001 Jul; 61(13):5307-10. PubMed ID: 11431375
[TBL] [Abstract][Full Text] [Related]
2. Expression of peroxisome proliferator-activated receptor gamma and the growth inhibitory effect of its synthetic ligands in human salivary gland cancer cell lines.
Begum NM; Nakashiro K; Kawamata H; Uchida D; Shintani S; Ikawa Y; Sato M; Hamakawa H
Int J Oncol; 2002 Mar; 20(3):599-605. PubMed ID: 11836575
[TBL] [Abstract][Full Text] [Related]
3. Novel expression and function of peroxisome proliferator-activated receptor gamma (PPARgamma) in human neuroblastoma cells.
Han SW; Greene ME; Pitts J; Wada RK; Sidell N
Clin Cancer Res; 2001 Jan; 7(1):98-104. PubMed ID: 11205925
[TBL] [Abstract][Full Text] [Related]
4. Frequent polymorphism of peroxisome proliferator activated receptor gamma gene in colorectal cancer containing wild-type K-ras gene.
Tomita S; Kawamata H; Imura J; Omotehara F; Ueda Y; Fujimori T
Int J Mol Med; 2002 May; 9(5):485-8. PubMed ID: 11956653
[TBL] [Abstract][Full Text] [Related]
5. Activation of peroxisome proliferator-activated receptor gamma by a novel synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest and apoptosis in breast cancer cells.
Lapillonne H; Konopleva M; Tsao T; Gold D; McQueen T; Sutherland RL; Madden T; Andreeff M
Cancer Res; 2003 Sep; 63(18):5926-39. PubMed ID: 14522919
[TBL] [Abstract][Full Text] [Related]
6. Decreased expression of peroxisome proliferator activated receptor gamma in cftr-/- mice.
Ollero M; Junaidi O; Zaman MM; Tzameli I; Ferrando AA; Andersson C; Blanco PG; Bialecki E; Freedman SD
J Cell Physiol; 2004 Aug; 200(2):235-44. PubMed ID: 15174093
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor gamma ligands induce growth inhibition and apoptosis of human B lymphocytic leukemia.
Zang C; Liu H; Posch MG; Waechter M; Facklam M; Fenner MH; Ruthardt M; Possinger K; Phillip Koeffler H; Elstner E
Leuk Res; 2004 Apr; 28(4):387-97. PubMed ID: 15109539
[TBL] [Abstract][Full Text] [Related]
8. Primary culture model of peroxisome proliferator-activated receptor gamma activity in prostate cancer cells.
Xu Y; Iyengar S; Roberts RL; Shappell SB; Peehl DM
J Cell Physiol; 2003 Jul; 196(1):131-43. PubMed ID: 12767049
[TBL] [Abstract][Full Text] [Related]
9. Expression and functional role of peroxisome proliferator-activated receptor-gamma in ovarian folliculogenesis in the sheep.
Froment P; Fabre S; Dupont J; Pisselet C; Chesneau D; Staels B; Monget P
Biol Reprod; 2003 Nov; 69(5):1665-74. PubMed ID: 12890736
[TBL] [Abstract][Full Text] [Related]
10. Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells.
Han S; Inoue H; Flowers LC; Sidell N
Clin Cancer Res; 2003 Oct; 9(12):4627-35. PubMed ID: 14555539
[TBL] [Abstract][Full Text] [Related]
11. The increased expression of peroxisome proliferator-activated receptor-gamma1 in human breast cancer is mediated by selective promoter usage.
Wang X; Southard RC; Kilgore MW
Cancer Res; 2004 Aug; 64(16):5592-6. PubMed ID: 15313896
[TBL] [Abstract][Full Text] [Related]
12. Reduced transcription of the RB2/p130 gene in human lung cancer.
Xue Jun H; Gemma A; Hosoya Y; Matsuda K; Nara M; Hosomi Y; Okano T; Kurimoto F; Seike M; Takenaka K; Yoshimura A; Toyota M; Kudoh S
Mol Carcinog; 2003 Nov; 38(3):124-9. PubMed ID: 14587097
[TBL] [Abstract][Full Text] [Related]
13. Expression of peroxisome proliferator-activated receptor (PPAR)-gamma in human lung cancer.
Inoue K; Kawahito Y; Tsubouchi Y; Yamada R; Kohno M; Hosokawa Y; Katoh D; Bishop-Bailey D; Hla T; Sano H
Anticancer Res; 2001; 21(4A):2471-6. PubMed ID: 11724309
[TBL] [Abstract][Full Text] [Related]
14. Activation of PPAR{gamma} by curcumin inhibits Moser cell growth and mediates suppression of gene expression of cyclin D1 and EGFR.
Chen A; Xu J
Am J Physiol Gastrointest Liver Physiol; 2005 Mar; 288(3):G447-56. PubMed ID: 15486348
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor gamma and cancers.
Koeffler HP
Clin Cancer Res; 2003 Jan; 9(1):1-9. PubMed ID: 12538445
[TBL] [Abstract][Full Text] [Related]
16. Growth-inhibitory effect of a novel synthetic triterpenoid, 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, on ovarian carcinoma cell lines not dependent on peroxisome proliferator-activated receptor-gamma expression.
Melichar B; Konopleva M; Hu W; Melicharova K; Andreeff M; Freedman RS
Gynecol Oncol; 2004 Apr; 93(1):149-54. PubMed ID: 15047229
[TBL] [Abstract][Full Text] [Related]
17. Activation of peroxisome proliferator-activated receptor gamma does not explain the antiproliferative activity of the nonsteroidal anti-inflammatory drug indomethacin on human colorectal cancer cells.
Hawcroft G; Gardner SH; Hull MA
J Pharmacol Exp Ther; 2003 May; 305(2):632-7. PubMed ID: 12606626
[TBL] [Abstract][Full Text] [Related]
18. Expression of peroxisome proliferator-activated receptor gamma in salivary duct carcinoma: immunohistochemical analysis of 15 cases.
Mukunyadzi P; Ai L; Portilla D; Barnes EL; Fan CY
Mod Pathol; 2003 Dec; 16(12):1218-23. PubMed ID: 14681322
[TBL] [Abstract][Full Text] [Related]
19. PPARgamma ligands inhibit cholangiocarcinoma cell growth through p53-dependent GADD45 and p21 pathway.
Han C; Demetris AJ; Michalopoulos GK; Zhan Q; Shelhamer JH; Wu T
Hepatology; 2003 Jul; 38(1):167-77. PubMed ID: 12829999
[TBL] [Abstract][Full Text] [Related]
20. Defining a common region of deletion at 13q21 in human cancers.
Chen C; Brabham WW; Stultz BG; Frierson HF; Barrett JC; Sawyers CL; Isaacs JT; Dong JT
Genes Chromosomes Cancer; 2001 Aug; 31(4):333-44. PubMed ID: 11433524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
